Balyasny Asset Management
SSRI

Balyasny Asset Management’s Silver Standard Resources SSRI Stock Holding History

Balyasny Asset Management’s Portfolio SSRI Stock Details SSRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-50,294
Closed -$488K – 2240
2017
Q2 		$488K Buy
50,294
+9,494
+23% +$95.4K ﹤0.01% 1236
2017
Q1 		$433K Buy
40,800
+2,900
+8% +$30.7K ﹤0.01% 1321
2016
Q4 		$338K Buy
+37,900
New +$383K ﹤0.01% 1204

Other funds holding SSRI

SCP
Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

Balyasny Asset Management's SSRI Position: Q3 2017 in Review

Balyasny Asset Management sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 50,294 shares — an estimated $488K sold.

Balyasny Asset Management first reported a position in SSRI in Q4 2016 and held it in 3 quarters. The position peaked at $488K in Q2 2017. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

  • Balyasny Asset Management reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
  • Balyasny Asset Management sold 50,294 Silver Standard Resources shares in Q3 2017, an estimated $488K.
  • Balyasny Asset Management first reported a position in Silver Standard Resources in Q4 2016 and held it in 3 quarters.
  • Balyasny Asset Management's Silver Standard Resources position peaked at $488K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on Balyasny Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.